ohmson.bsky.social
ohmson.bsky.social
@ohmson.bsky.social
$MESO is up 100% in the last 3 months because Remestemcel-L's PDUFA is 1/7/25. It had 2 CRLs in the past: Sep 2020 and Aug 2023. This is an Australia biotech but stem-cell doesn't have a good rep as modality. Questions:
- is selling Dec $15P option very safe
- is shorting commons into PDUFA safe?
December 1, 2024 at 7:29 PM
Reposted by ohmson.bsky.social
Biotech boss tells Europe to invest if it wants a homegrown sector

https://on.ft.com/3S7cQ0E
Biotech boss tells Europe to invest if it wants a homegrown sector
Argenx is one of the bloc’s largest biotech companies but its shareholder base is dominated by US specialist investors
on.ft.com
January 5, 2024 at 5:00 AM